KR102435658B1 - 니코틴 백신 개발을 위한 광학순도 합텐 - Google Patents

니코틴 백신 개발을 위한 광학순도 합텐 Download PDF

Info

Publication number
KR102435658B1
KR102435658B1 KR1020167035358A KR20167035358A KR102435658B1 KR 102435658 B1 KR102435658 B1 KR 102435658B1 KR 1020167035358 A KR1020167035358 A KR 1020167035358A KR 20167035358 A KR20167035358 A KR 20167035358A KR 102435658 B1 KR102435658 B1 KR 102435658B1
Authority
KR
South Korea
Prior art keywords
nicotine
hapten
antibodies
vaccine
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020167035358A
Other languages
English (en)
Korean (ko)
Other versions
KR20170007810A (ko
Inventor
김 디. 잔다
조나단 더블유. 로크너
Original Assignee
더 스크립스 리서치 인스티튜트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 더 스크립스 리서치 인스티튜트 filed Critical 더 스크립스 리서치 인스티튜트
Publication of KR20170007810A publication Critical patent/KR20170007810A/ko
Application granted granted Critical
Publication of KR102435658B1 publication Critical patent/KR102435658B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0013—Therapeutic immunisation against small organic molecules, e.g. cocaine, nicotine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/16—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
    • Y10S514/813—

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Botany (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Addiction (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020167035358A 2014-05-19 2015-05-19 니코틴 백신 개발을 위한 광학순도 합텐 Active KR102435658B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462000312P 2014-05-19 2014-05-19
US62/000,312 2014-05-19
PCT/US2015/031583 WO2015179403A1 (en) 2014-05-19 2015-05-19 Enantiopure haptens for nicotine vaccine development

Publications (2)

Publication Number Publication Date
KR20170007810A KR20170007810A (ko) 2017-01-20
KR102435658B1 true KR102435658B1 (ko) 2022-08-23

Family

ID=54554631

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020167035358A Active KR102435658B1 (ko) 2014-05-19 2015-05-19 니코틴 백신 개발을 위한 광학순도 합텐

Country Status (8)

Country Link
US (3) US20170107275A1 (https=)
EP (1) EP3145920B1 (https=)
JP (1) JP6564396B2 (https=)
KR (1) KR102435658B1 (https=)
CN (2) CN110452217B (https=)
AU (1) AU2015264325B2 (https=)
CA (1) CA2949667C (https=)
WO (1) WO2015179403A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170107275A1 (en) 2014-05-19 2017-04-20 The Scripps Research Institute Enantiopure haptens for nicotine vaccine development
CN118161604B (zh) * 2024-03-25 2025-01-14 海南大学 一种尼古丁蛋白缀合物、其制备方法及在疫苗中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110217320A1 (en) 1998-12-01 2011-09-08 Nabi Biopharmaceuticals Hapten-carrier conjugates for treating and preventing nicotine addiction
US20130131015A1 (en) 2006-03-29 2013-05-23 North Carolina State University Synthesis and regioselective substitution of 6-halo- and 6-alkoxy nicotine derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5876727A (en) * 1995-03-31 1999-03-02 Immulogic Pharmaceutical Corporation Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
SE9801923D0 (sv) * 1998-05-29 1998-05-29 Independent Pharmaceutical Ab Nicotine vaccine
EP1963308A4 (en) * 2005-11-28 2010-12-15 Nabi Biopharmaceuticals METHOD FOR PRODUCING A NICOTINE HAPTEN
WO2007100755A1 (en) * 2006-02-27 2007-09-07 Nabi Biopharmaceuticals Method for decreasing the toxic effects of nicotine on fetuses in pregnant women
TWI578997B (zh) * 2010-06-04 2017-04-21 輝瑞疫苗有限責任公司 用於預防或治療菸鹼成癮之共軛體
US20170107275A1 (en) 2014-05-19 2017-04-20 The Scripps Research Institute Enantiopure haptens for nicotine vaccine development
US9884114B2 (en) * 2015-06-23 2018-02-06 Arizona Board Of Regents On Behalf Of Arizona State University Methods of rational nicotine hapten design and uses thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110217320A1 (en) 1998-12-01 2011-09-08 Nabi Biopharmaceuticals Hapten-carrier conjugates for treating and preventing nicotine addiction
US20130131015A1 (en) 2006-03-29 2013-05-23 North Carolina State University Synthesis and regioselective substitution of 6-halo- and 6-alkoxy nicotine derivatives

Also Published As

Publication number Publication date
CN110452217A (zh) 2019-11-15
JP6564396B2 (ja) 2019-08-21
EP3145920A1 (en) 2017-03-29
CN110452217B (zh) 2022-12-27
US20190119363A1 (en) 2019-04-25
US10487141B2 (en) 2019-11-26
CN106458971A (zh) 2017-02-22
JP2017515867A (ja) 2017-06-15
US20170107275A1 (en) 2017-04-20
CA2949667C (en) 2022-05-03
WO2015179403A1 (en) 2015-11-26
AU2015264325A1 (en) 2016-12-01
EP3145920B1 (en) 2019-09-18
US20180086820A1 (en) 2018-03-29
CA2949667A1 (en) 2015-11-26
KR20170007810A (ko) 2017-01-20
EP3145920A4 (en) 2017-12-27
AU2015264325B2 (en) 2019-02-14

Similar Documents

Publication Publication Date Title
JP4971542B2 (ja) ニコチン中毒の治療及び予防のためのハプテン−キャリア複合体
KR101429413B1 (ko) 니코틴 중독의 예방 또는 치료를 위한 접합체
US10487141B2 (en) Enantiopure haptens for nicotine vaccine development
CN102781929A (zh) 尼古丁半抗原、免疫偶联物及它们的用途
HK1091415B (en) Hapten-carrier conjugates for treating and preventing nicotine addiction
HK1075824A (en) Hapten-carrier conjugates for treating and preventing nicotine addiction

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20161216

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20200513

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20211202

Patent event code: PE09021S01D

E90F Notification of reason for final refusal
PE0902 Notice of grounds for rejection

Comment text: Final Notice of Reason for Refusal

Patent event date: 20220222

Patent event code: PE09021S02D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20220608

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20220819

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20220819

End annual number: 3

Start annual number: 1

PG1601 Publication of registration